← Leaderboards
Yana Pikman
Dana-Farber Cancer Inst
$885,600
Attributed
$885,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $177.1K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$885,600 · 1
By mechanism
K08$885,600 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Alejandro Gutierrez$7,788,333
- Tracy T Batchelor$27,819,477
- Rochelle Bagatell$1,843,838
- Rameen Beroukhim$9,639,646
- Kira O. Bona$1,544,325
Others in their field
Other Emerging Leaders on “Acute Lymphocytic Leukemia”
- Crystal Mackall · Children'S Hosp Of Philadelphia$12,361,966
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$8,557,384
- Adam De Smith · University Of Southern California$5,277,579
- Karen R Rabin · Baylor College Of Medicine$4,946,686
- Ernesto Guccione · Icahn School Of Medicine At Mount Sinai$4,876,508
Research focus
Acute Lymphocytic LeukemiaAcute Myelocytic LeukemiaAcute Myeloid Leukemia CellAcute T Cell LeukemiaAcute T-Cell Lymphoblastic Leukemia CellAdultAdvisory CommitteesAlpha KetoglutarateAnticancer ResearchApoptosisAreaAsparaginaseAwardB-Cell Acute Lymphoblastic LeukemiaBlastomere StructureBostonCancer CellCancer EtiologyCarbeneCarbonCareerCell CycleCell LineAcute Leukemia
Grant awards (5)
Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy$177,120
K08 · FY2022 · CA · contact PI
Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy$177,120
K08 · FY2021 · CA · contact PI
Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy$177,120
K08 · FY2020 · CA · contact PI
Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy$177,120
K08 · FY2019 · CA · contact PI
Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy$177,120
K08 · FY2018 · CA · contact PI